title: [Systemic lupus erythematosus: study of 48 patients with emphasis on renal involvement].
authors.forename: M de L
authors.initials: Mde L
authors.lastname: Boas
authors.forename: E E
authors.initials: EE
authors.lastname: Nakayama
authors.forename: M F
authors.initials: MF
authors.lastname: Carvalho
authors.forename: J F
authors.initials: JF
authors.lastname: Delfino Filho
authors.forename: S L
authors.initials: SL
authors.lastname: Neiva
authors.forename: F
authors.initials: F
authors.lastname: Habermann
authors.forename: R J
authors.initials: RJ
authors.lastname: Franco
authors.forename: V A
authors.initials: VA
authors.lastname: Soares
authors.forename: D B
authors.initials: DB
authors.lastname: de Almeida
mesh_terms: D000293:Adolescent; D000328:Adult; D002648:Child; D003404:Creatinine / Q000097:blood; D003520:Cyclophosphamide / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007668:Kidney / Q000503:physiopathology*; D008180:Lupus Erythematosus, Systemic / Q000097:blood / Q000188:drug therapy / Q000503:physiopathology*; D008181:Lupus Nephritis / Q000097:blood / Q000503:physiopathology; D008297:Male; D008875:Middle Aged; D011241:Prednisone / Q000627:therapeutic use; D011379:Prognosis; D012189:Retrospective Studies
chemical_list: D003520:Cyclophosphamide; D003404:Creatinine; D011241:Prednisone
vernacular_title: Lúpus eritematoso sistêmico: estudo de 48 pacientes com ênfase no comprometimento renal.